Showing 2091-2100 of 3303 results for "".
New Products
https://practicaldermatology.com/columns/new-products/new-products/20472/Just One More Thing
https://practicaldermatology.com/topics/practice-management/just-one-more-thing/20558/One more thing can be a nuisance...or an opportunity to make a difference.Cures All
https://practicaldermatology.com/topics/practice-management/cures-all/20771/What will the 21st Century Cures Act mean for dermatologists?From the Neck Down
https://practicaldermatology.com/topics/practice-management/from-the-neck-down/20781/Exploring other uses for Allergan's KybellaUpdate: Oral Therapies for the Treatment of BCC
https://practicaldermatology.com/topics/practice-management/update-oral-therapies-for-the-treatment-of-bcc/21132/With the recent FDA approval of a new oral agent, the therapeutic outlook for BCC is both more diverse and promising.Recently Passed Law Clears Way for New Sunscreen Ingredients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/recently-passed-law-clears-way-for-new-sunscreen-ingredients/21232/By forcing the FDA to clear its backlog of sunscreen ingredients pending review, The Sunscreen Innovation Act is a major win for UV protection efforts.New Products
https://practicaldermatology.com/columns/new-products/new-products/21262/The Molecular Era in Melanoma Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-molecular-era-in-melanoma-treatment/21296/Melanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.Analyzing Risk Factors for Subsequent Primary Melanomas
https://practicaldermatology.com/topics/skin-cancer-photoprotection/analyzing-risk-factors-for-subsequent-primary-melanomas/21429/